Publications by authors named "Wim Maes"

Claim this Profile
C
Complementarity determining regions in SARS-CoV-2 hybrid immunity.
Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Wim Maes

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model.
Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Piet Maes

iScience· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.
Bas Calcoen, Nico Callewaert, Aline Vandenbulcke, Winnie Kerstens, Maya Imbrechts, Piet Maes, Wim Maes

Viruses· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood.
Jia-Huan Qu, Karen Leirs, Wim Maes, Maya Imbrechts, Nico Callewaert

ACS Sens· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon, Stéphanie Liénart, Orian Bricard, Wim Maes

Nat Commun· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion.
Willem Delabie, Wim Maes, Rosalie Devloo, Michelle R Van den Hauwe, Karen Vanhoorelbeke

Transfusion· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Introduction of a Full Medication Review Process in a Local Hospital: Successes and Barriers of a Pilot Project in the Geriatric Ward.
Lies De Bock, Eline Tommelein, Hans Baekelandt, Wim Maes, Koen Boussery

Pharmacy (Basel)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretargeted PET Imaging Using a Bioorthogonal F-Labeled trans-Cyclooctene in an Ovarian Carcinoma Model.
Emilie M F Billaud, Sarah Belderbos, Frederik Cleeren, Wim Maes, Marlies Van de Wouwer

Bioconjug Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of platelet and endothelial GARP in thrombosis and hemostasis.
Elien Vermeersch, Frederik Denorme, Wim Maes, Simon F De Meyer, Karen Vanhoorelbeke

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Tina Verschuere, Jaan Toelen, Wim Maes, Françoise Poirier, Louis Boon

Int J Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain.
Wim Maes, Tina Verschuere, Anaïs Van Hoylandt, Louis Boon, Stefaan Van Gool

Clin Dev Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foxp3+ regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade.
Isabel Vogel, Bert Verbinnen, Wim Maes, Louis Boon, Stefaan W Van Gool

Eur J Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
Hilko Ardon, Stefaan W Van Gool, Tina Verschuere, Wim Maes, Steffen Fieuws

Cancer Immunol Immunother· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.
Sofie Vets, Janine Kimpel, Andreas Volk, Jan De Rijck, Rik Schrijvers, Wim Maes

Mol Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
Wim Maes, Stefaan W Van Gool

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.
Hilko Ardon, Stefaan Van Gool, Isabel Spencer Lopes, Wim Maes, Raf Sciot

J Neurooncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haptoglobin deficiency facilitates the development of autoimmune inflammation.
Georgina Galicia, Wim Maes, Bert Verbinnen, Ahmad Kasran, Dominique Bullens

Eur J Immunol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.
Wim Maes, Georgina Galicia Rosas, Bert Verbinnen, Louis Boon, Steven De Vleeschouwer

Neuro Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell therapy of high-grade gliomas.
Stefaan Van Gool, Wim Maes, Hilko Ardon, Tina Verschuere, Sofie Van Cauter

Brain Pathol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
An Coosemans, Philippe Moerman, Godelieve Verbist, Wim Maes, Patrick Neven

Gynecol Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells.
Wim Maes, John Van Camp, Vanessa Vermeirssen, Mattias Hemeryck, Jean Marie Ketelslegers

Regul Pept· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis